Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Operating Expenses (2024 - 2025)

Historic Operating Expenses for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $32.2 million.

  • Beta Bionics' Operating Expenses rose 6169.12% to $32.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $116.9 million, marking a year-over-year increase of 10717.92%. This contributed to the annual value of $81.1 million for FY2024, which is 9246.41% up from last year.
  • As of Q3 2025, Beta Bionics' Operating Expenses stood at $32.2 million, which was up 6169.12% from $32.4 million recorded in Q2 2025.
  • Beta Bionics' 5-year Operating Expenses high stood at $32.4 million for Q2 2025, and its period low was $16.7 million during Q1 2024.